Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 2756
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49762
Couldn't have said it better myself. Tired of
(1)
Kelt
10/11/2018 4:34:15 PM
49761
Kelt, Leo cant use Aspire because the SP is
(1)
sox0407
10/11/2018 4:33:47 PM
49760
Shame that some people don't understand or
Kelt
10/11/2018 4:30:51 PM
49759
It doesn't matter what kind of a deal Leo makes,
(4)
Drano
10/11/2018 4:29:32 PM
49758
He didn't need to have the deal with Aspire this
Kelt
10/11/2018 4:26:06 PM
49757
Oh come on. The company is only taking 2.2
Drano
10/11/2018 4:24:57 PM
49756
If you don't think this is toxic financing you
bejamin
10/11/2018 4:18:21 PM
49755
I dont think we could rely on Aspire because the
(1)
Squar
10/11/2018 4:06:30 PM
49754
I may be wrong but Leo could have just continued
(6)
Kelt
10/11/2018 3:52:19 PM
49753
Great level headed info. Thank you. I also know
(6)
DaubersUP
10/11/2018 3:17:51 PM
49752
Daubers, great post over there! I doubt the MFO
(3)
sox0407
10/11/2018 3:02:41 PM
49751
Generous group of MM's filled my order today for
AlanC
10/11/2018 3:01:24 PM
49750
It's all about potential. $2b for this startup
(3)
smokenhot
10/11/2018 2:50:57 PM
49749
The financing deal this week makes it almost
Squar
10/11/2018 2:16:27 PM
49748
Daubers: IMHO Leo and team know exactly what is
(1)
AlanC
10/11/2018 2:03:53 PM
49747
Yes, Scotty is certainly in hot water over there.
Squar
10/11/2018 1:53:13 PM
49746
Ill be right there with you brother. Bought a
Squar
10/11/2018 1:50:09 PM
49745
According to 7th grad math class, 20 x 0 =
Drano
10/11/2018 1:49:42 PM
49744
The so-called Level 2 was showing over 50k on the
(1)
Drano
10/11/2018 1:49:07 PM
49743
I wish. That would make me a big winner. Then I
Squar
10/11/2018 1:48:19 PM
49742
Hey Squar you know TheBunny over at your main
(2)
smokenhot
10/11/2018 1:43:50 PM
49741
I going to be more than happy to sell those
(1)
Loose Lips
10/11/2018 1:42:54 PM
49740
Let me fix that for you. You meant to write "I
(2)
Drano
10/11/2018 1:35:56 PM
49739
Yeesh....I bought shares at 3.40. Now that's a
Squar
10/11/2018 1:35:04 PM
49738
Those might be some of the shares I bought. My
(2)
Loose Lips
10/11/2018 12:56:11 PM
49737
Daubers it's known we are waiting on BTD
smokenhot
10/11/2018 12:43:59 PM
49736
Agree that we have raised $ and should at least
(2)
zdubble17
10/11/2018 12:43:12 PM
49735
I go agree. Ive now added over 60K shares
(1)
DaubersUP
10/11/2018 12:36:59 PM
49734
DaubersUP even at 16 million shares, that is only
(1)
zdubble17
10/11/2018 12:14:59 PM
49733
Alan. We need a deal or some kind of promising
(1)
DaubersUP
10/11/2018 12:06:00 PM
49732
Volume was around 500k but has flatlined for
Drano
10/11/2018 11:39:30 AM
49731
At 11:30 or two hours into the trading day volume
AlanC
10/11/2018 11:33:54 AM
49730
I would buy the .17's and consider yourself
(3)
AlanC
10/11/2018 9:57:08 AM
49729
The financing deal put my solvency concerns to
(1)
Squar
10/11/2018 9:53:55 AM
49728
Convinced me to pick up a bit more here Zdub.
Squar
10/11/2018 9:51:30 AM
49727
Good point. I have always felt that as painful as
(4)
Loose Lips
10/11/2018 9:50:53 AM
49726
It is what it is.
Kelt
10/11/2018 9:16:58 AM
49725
Sub penny thoughts are a bunch of nonsense. That
scgmck1
10/11/2018 8:59:45 AM
49724
I think what cracks me up is that this company
(11)
zdubble17
10/11/2018 8:50:52 AM
49723
yeah that will show the crooks. I got my sub
(2)
Jimmyboy
10/11/2018 8:49:04 AM
49722
If they are foolish enough do that, they will
(2)
scgmck1
10/11/2018 8:36:33 AM
49721
Really? Squar don't show your motive that easy.
zdubble17
10/11/2018 8:28:11 AM
49720
Anyone have a guess on trading? Are 0.17s the buy
(2)
Squar
10/11/2018 7:58:02 AM
49719
Priority review accompanying BTD for B-OM - yes.
(1)
Squar
10/10/2018 10:13:29 PM
49718
Included in it is "Material threat medical
(1)
Squar
10/10/2018 10:08:50 PM
49717
DaubersUp in the Swamp had a good post. Yes there
(6)
Trading Pro Broker
10/10/2018 8:55:06 PM
49716
Priority Review could/would be used in the
Kelt
10/10/2018 8:49:09 PM
49715
This is the list of criteria for a drug to meet
(2)
Kelt
10/10/2018 8:43:51 PM
49714
42% marked today and this does not include the
(1)
AlanC
10/10/2018 5:46:54 PM
49713
PRV is usually awarded for Orphan Drug
(1)
Squar
10/10/2018 5:35:10 PM
Newer
Older
Recent Articles
AST SpaceMobile Faces Stock Drop Amid Financial Moves
Brompton Funds Unveils Monthly Distributions for Investors
Remarkable Growth of Marathon Petroleum in the Last Five Years
Ovintiv's Q2 2025 Performance: Key Highlights and Guidance
Boston Beer Company Reports Mixed Q2 Results with Growth Insights
Genuine Article Celebrates National Award Recognition
Korsail Energy Launches New Guidelines for Community Engagement
Boise to Celebrate Basque Heritage with Massive Festival
Exploring the Future of B7-H4 Targeted Cancer Therapies
Hold Me Ltd. Acquires Synthetic Darwin to Enhance AI Capabilities
Upcoming Release of EZCORP's Q3 Fiscal Results and Insights
Innovative Gold-Backed Stablecoin Revolutionizes African Creators
EZCORP Set to Announce Q3 Fiscal 2025 Results Soon
Opendoor Takes the Lead in the New Meme Stock Surge
Carriage Services Set to Release Q2 Earnings and Call Details
Hammond Power Solutions Achieves Record Sales in Q2 2025
Gold Royalty Corp. Hits New Revenue Heights in Q2 2025
Celebrating Ajinomoto Foods' Inspiring Workplace Achievement
Discover Cozy Chickens' Innovative Brooder Habitat for Chicks
Minerals Technologies' Impressive Second Quarter Results of 2025
Hammond Power Solutions Achieves Record Sales in 2025
Heritage Commerce Corp's Latest Dividend Announcement for Investors
Algernon Pharmaceuticals Completes Strategic Financing for Growth
Team, Inc. Elevates Daniel Dolson to Drive Major Changes
Brompton Funds Unveils New Monthly Distributions for Investors
Unlocking the Long-Term Value of Graphic Packaging Holding Stock
Heritage Commerce Corp Welcomes Seth Fonti as CFO
Ingersoll Rand Inc: Analyzing P/E Ratio Dynamics for Investors
Heritage Commerce Corp Announces Quarterly Cash Dividend Increase
GO Residential REIT Moves Forward with Initial Public Offering
Scienture Holdings Secures Critical Funding for Growth Initiative
InterRent REIT to Release Second Quarter Financial Results Soon
Team, Inc. Appoints New Executive to Spearhead Change
Upcoming Earnings Call for Carriage Services: What to Know
Atlas Engineered Products Expands Reach with New Acquisition
Ocean Power Technologies Reports Impressive Fiscal Performance
Weyerhaeuser Company Reports Strong Q2 2025 Financial Gains
Gold Royalty Corp. Achieves Milestone Revenue in Q2 2025
Eni's Imminent Earnings Report Promises Investor Insights
Weyerhaeuser's Latest Financial Performance Insights Revealed
Aris Mining Sets Date for Exciting Q2 2025 Financial Results
Ovintiv's Impressive Financial Performance for Q2 of 2025
Ecovyst Plans Earnings Call to Discuss Growth Strategies
QuickBooks Advances Small Business Success with AI Innovations
Corporate America: Navigating Q2 Earnings and Future Prospects
Ninepoint Partners Releases Latest Cash Distribution Details
ReShape Lifesciences' Meeting Outcomes and Strategic Focus Ahead
ADT Inc. Introduces Secondary Offering with Share Repurchase
Google's Support for Blockchain Games Shapes Future of Web3
Neogen Corporation Class Action Lawsuit Information for Investors